16th July 2024

Medical research to benefit from TRI imaging boost

Imaging scientist to join global experts to explore technology advances

Latest News

16 April 2021

Potential New Treatment Could Help Save COVID-19 Patients

Anti-inflammatory drug, IC14, enters Phase II clinical trial to treat severely ill COVID-19 patients.
More about Potential New Treatment Could Help Save COVID-19 Patients
25 March 2021

US Department of Defense breast cancer grant

Dr Fernando Guimaraes has been awarded US$750K to progress a new breast cancer treatment
More about US Department of Defense breast cancer grant
24 March 2021

Breakthrough therapy cures lymphoma patient

A Mater Research team has cured a patient of a rare type of lymphoma
More about Breakthrough therapy cures lymphoma patient
24 March 2021

Anticancer and Antimicrobial peptide treatments

QUT's Dr Sónia Henriques, is developing selective and potent anticancer peptide-based treatments.
More about Anticancer and Antimicrobial peptide treatments
22 March 2021

New funding for COVID-19 research

Mater Research's TRI-based Dr Mitchell Sullivan has received funding for a COVID-19 research project.
More about New funding for COVID-19 research

Pages

Events

29 July 2024 12:00 PM2:00 PM

First Responder Training

To continue to provide a safe and supportive workplace, TRI is offering First Responder Training. This training is open to all staff and students at TRI and aims to empower individuals to be a point of contact and source of information and referral for individuals who have experienced sexual harassment or assault.
More about First Responder Training
30 July 2024 12:00 PM1:00 PM

2024 Game Changer Series - Seminar #1

Join us for the first instalment of the TRI Game Changer Seminar Series for 2024. Professor Steve Wesselingh FRACP FAHMS, Chief Executive Officer at the National Health and Medical Research Council (NHMRC), will speak about the ‘Future direction of the NHMRC’.
More about 2024 Game Changer Series - Seminar #1